ES2162092T3 - Terapia de combinacion para canceres avanzados que comprende temozolomida y cisplatino. - Google Patents

Terapia de combinacion para canceres avanzados que comprende temozolomida y cisplatino.

Info

Publication number
ES2162092T3
ES2162092T3 ES96930553T ES96930553T ES2162092T3 ES 2162092 T3 ES2162092 T3 ES 2162092T3 ES 96930553 T ES96930553 T ES 96930553T ES 96930553 T ES96930553 T ES 96930553T ES 2162092 T3 ES2162092 T3 ES 2162092T3
Authority
ES
Spain
Prior art keywords
cisplatin
combination therapy
advanced cancers
temozolomide
includes temozolomide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96930553T
Other languages
English (en)
Inventor
Margaret H Dugan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ES2162092T3 publication Critical patent/ES2162092T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

SE DESCRIBE UN PROCEDIMIENTO PARA TRATAR EL CANCER AVANZADO EN PACIENTES QUE NECESITEN ESTE TRATAMIENTO. LA TEMOZOLAMIDA Y LA CISPLATINA SE ADMINISTRAN JUNTAS EN CANTIDADES SUFICIENTES PARA LOGRAR UNA RESPUESTA CLINICA.
ES96930553T 1995-08-28 1996-08-26 Terapia de combinacion para canceres avanzados que comprende temozolomida y cisplatino. Expired - Lifetime ES2162092T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US287795P 1995-08-28 1995-08-28
US62479596A 1996-03-27 1996-03-27

Publications (1)

Publication Number Publication Date
ES2162092T3 true ES2162092T3 (es) 2001-12-16

Family

ID=26670993

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96930553T Expired - Lifetime ES2162092T3 (es) 1995-08-28 1996-08-26 Terapia de combinacion para canceres avanzados que comprende temozolomida y cisplatino.

Country Status (11)

Country Link
EP (1) EP0858341B1 (es)
JP (1) JPH10511108A (es)
AT (1) ATE207359T1 (es)
AU (1) AU6955396A (es)
CA (1) CA2229141A1 (es)
DE (1) DE69616367T2 (es)
DK (1) DK0858341T3 (es)
ES (1) ES2162092T3 (es)
GR (1) GR3037047T3 (es)
PT (1) PT858341E (es)
WO (1) WO1997007804A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE330600T1 (de) * 2000-01-26 2006-07-15 Schering Corp Kombinationspräparat zur krebstherapie
US20070265324A1 (en) * 2006-01-17 2007-11-15 Wolfgang Wernet Combination Therapy with Parp Inhibitors
EP2004148B1 (en) 2006-04-05 2015-07-15 OPKO Health, Inc. Pharmaceutical formulations comprising salts of (5S,8S)-8-[{(1 R)-1-(3,5-Bis-trifluoromethyl)phenyl]- ethoxy}-methyl]-8-phenyl-1 ,7-diazaspiro[4.5]decan-2-one and their medical use
ES2584838T3 (es) 2006-04-05 2016-09-29 Opko Health, Inc Sal clorhidrato de 8-[{1-(3,5-bis-(trifluorometil)fenil)-etoxi}-metil]-8-fenil-1,7-diaza-espiro[4.5]decán-2-ona y procedimiento de preparación de la misma
EP2379080A1 (en) * 2009-01-13 2011-10-26 ProteoSys AG Pirenzepine as otoprotective agent
CA3164592A1 (en) * 2020-01-13 2021-07-22 Luis Alberto Diaz Methods and compositions for cancer immunotherapy

Also Published As

Publication number Publication date
DK0858341T3 (da) 2001-11-19
AU6955396A (en) 1997-03-19
EP0858341A1 (en) 1998-08-19
GR3037047T3 (en) 2002-01-31
MX9801585A (es) 1998-05-31
WO1997007804A1 (en) 1997-03-06
DE69616367T2 (de) 2002-06-27
DE69616367D1 (de) 2001-11-29
PT858341E (pt) 2002-03-28
CA2229141A1 (en) 1997-03-06
EP0858341B1 (en) 2001-10-24
ATE207359T1 (de) 2001-11-15
JPH10511108A (ja) 1998-10-27

Similar Documents

Publication Publication Date Title
KR950700749A (ko) 2'-할로메틸리덴 유도체와 S-기 또는 M-기 특이성 항종양제를 사용하는 결합치료에 의한 암치료 방법(Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and a S-phase or M phase specific antineoplastic agent)
HK1046093A1 (en) Docetaxel in combination with rhumab her2 for the treatment of cancers.
PT880350E (pt) Tratamento de esclerose multipla
FI971290A (fi) Multippeliskleroosin (MS) ja muiden myeliinikadosta aiheutuvien sairauksien hoito
PL323798A1 (en) Application of derivatives of vitamin d4 in treating skin diseases
CY1105564T1 (el) Θεραπεια συνδυασμου για καρκινο
ATE77230T1 (de) Melatoninhaltige mittel sowie deren verwendungen.
NZ504928A (en) Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases
ES2162092T3 (es) Terapia de combinacion para canceres avanzados que comprende temozolomida y cisplatino.
IL121440A0 (en) The use of 1,3,4,6-tetrahydroxy-helianthrone and its derivatives in photodynamic therapy and certain such novel derivatives
ES2183977T3 (es) Combinacion de temozolomida y alfa-interferon para el tratamiento de cancer avanzado.
ES2019713A6 (es) Un procedimiento para preparar derivados clorados de adenosina.
SU1823193A1 (ru) Способ лечения рака гортани
NO984198L (no) FremgangsmÕte for behandling av aggresjon
MX9603833A (es) Tratamiento mejorado del cancer con temozolomida.
WO2000033823A3 (en) Methods of using temozolomide in the treatment of cancers
RU94020918A (ru) Способ лечения опсоменореи
RU94003538A (ru) Способ повышения эффективности лучевой терапии
UA30126A (uk) Спосіб лікування пізнього гестозу вагітних

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 858341

Country of ref document: ES